Qingdao Baheal Medical INC. (SHE:301015)
23.27
-0.86 (-3.56%)
Sep 11, 2026, 11:25 AM CST
SHE:301015 Revenue
Qingdao Baheal Medical INC. had revenue of 1.78B CNY in the quarter ending June 30, 2026, a decrease of -7.05%. This brings the company's revenue in the last twelve months to 7.31B, down -6.87% year-over-year. In the year 2025, Qingdao Baheal Medical INC. had annual revenue of 7.51B, down -7.26%.
Revenue (ttm)
7.31B
Revenue Growth
-6.87%
P/S Ratio
1.73
Revenue / Employee
2.93M
Employees
2,493
Market Cap
12.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.51B | -587.94M | -7.26% |
| Dec 31, 2024 | 8.09B | -161.54M | -1.96% |
| Dec 31, 2023 | 8.26B | 746.38M | 9.94% |
| Dec 31, 2022 | 7.51B | 458.05M | 6.50% |
| Jan 1, 2022 | 7.05B | 1.17B | 19.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 289.46B |
| Jointown Pharmaceutical Group | 167.56B |
| C.Q. Pharmaceutical Holding | 81.39B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.91B |
| China National Accord Medicines Corporation | 72.89B |
| China National Medicines Corporation | 53.56B |
| China Meheco Group | 34.97B |
| Guangxi LiuYao Group | 21.15B |